In this work, the microwave radiation is adopted for remote activation of pharmaceutical drug capsules inside the human body in order to release drugs at a pre-determined time and location. An array of controllable transmitting sources is used to produce a constructive interference at a certain focus point inside the body, where the drugs are then released from the specially designed capsules. An experimental setup for microwave activation has been developed and tested on a body phantom that emulates the human torso. A design of sensitive receiving structures for integration with a drug capsule is presented.
Introduction
Between the years 2007 and 2010, almost 48% of the people in the United States took at least one prescription drug in a single month. The prescription drug use had increased by 8.4 % compared to the period 1988-1994 [1] . We mention US statistics here, because it is easily accessible, however, the situation in other countries is likely to be similar. With current increasing intake of drugs, a more efficient and controllable way of delivering the drugs is of a great interest.
Oral delivery of pharmaceuticals is the preferred method compared to intravenous injection because of lower costs, reduced risks associated with the procedure, and higher patient compliance due to self-administration. However, the traditional oral delivery faces several challenges such as low drug permeability (not to be confused with electromagnetic permeability) through the gastrointestinal epithelium [2, 3] and degradation of the active pharmaceutical components in the stomach [4] .
The problem of current drug delivery systems, e.g. in the form of pills, is the limited external control of the drug release process in the body. Typically, the drug release is controlled by the natural intestinal pH gradient, which results in the drug to be released over a large segment of the intestine. The drugs are coated with special protective coatings which dissolve at a certain pH value. The time and the location for the drug release is therefore difficult to control. For certain diseases though, such as schizophrenia and diabetes, dosing must be stable and reliable [5] .
Pharmaceutical drugs taken orally are normally designed to release the drug in the small intestine because there the drugs typically exhibit maximal absorption [6] . The small intestines are less than 3 cm in diameter [7, pp. 272] .
A number of techniques have been developed to externally control the drug delivery. These include the use of ultrasound [8] , light waves [9] , magnetic fields [10] and radio waves below 100 MHz [11] . Complex systems have also been integrated into a drug delivery module consisting of a receiving inductor, control circuitry chip and a drug delivery chip [12] . Each method has its pros and cons. The alternative method that described in this work is to focus microwave energy inside the human body to get localized high-amplitude fields. Those are then used to activate the specially designed micro-containers.
Microwave Activation of Drug Release
The purpose of the microwave activation system is to provide a method of releasing drugs inside the body, unobtrusively, i.e. without disturbing a patient. The concept is illustrated in Figure 1 , where one of the anticipated scenarios is illustrated. A person is lying on a bed, sleeping after having ingested numerous capsules that contain pharmaceutical drugs. At a certain time and at a pre-determined location inside the human body the microwave activation system focuses electromagnetic energy that opens the capsules and releases the medical drug.
Obviously, the essence of the external activation of pharmaceutical drugs with microwaves depends on the ability to induce electromagnetic power at certain areas inside the body. A documented side effect of being irradiated by electromagnetic waves is that, unwanted heating of areas, other than intended, can occur. A method for reducing this effect is to superimpose electromagnetic waves from multiple sources creating a focus point. Figure 1 . Remote activation of drug release using electromagnetic radiation.
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There are a number of critical design-choices to be made in a system which radiates electromagnetic waves inside the human body. These include operating frequency, number and location of transmitting antennas, pulsed vs. continuous wave operation, power level and flexibility of the system. Generally, with increasing frequency, attenuation in biological tissues increases and makes it more challenging to penetrate deeper into the body. Higher frequency is, however, able to focus onto smaller areas due to its smaller wavelength. Components, such as antennas, can be made smaller, which dictates the overall size of the system. Considering these tradeoffs, the operating frequency of the experimental setup described in this work has been chosen in ISM band and is approximately 2.45 GHz.
In Figure 2 , a schematic drawing of the implemented experimental setup is presented. A human torso phantom is in the center of the setup. To simplify the setup only four transmitters were implemented. They are evenly distributed around the phantom, as it is shown in the figure. Focusing of the electromagnetic energy is achieved by changing the amplitude and phase of the transmitted signal. Microwave absorbers are placed in the plane of measurement, where one is placed behind each transmitter and one between each transmitter as shown in the figure.
The submerged in the phantom sleeve dipole antenna (red dot in Figure 2 ) is mounted on the lid of the phantom and used as a probe for measuring the field distribution inside the phantom. The lid can be rotated 360 deg in a continuous movement. The submerged antenna can also be moved continuously back and forth, from the centre of the phantom.
In the conducted experiments a number of arbitrary focusing points were pre-determined in order to examine the focusing abilities of the microwave activation system. The experimental data showed clear focusing points at the predetermined locations for points less than 4 cm from the centre of the phantom, i.e. deep inside the lossy phantom. In those cases, the focus point is the highest amplitude-point across a diameter larger than 3.6 cm. For comparison, the small intestine in humans are typically less than 3 cm in diameter [7, pp. 272] and is the place where the drug release is meant to take place. High-amplitude areas and spots (hot spots) appeared also at other locations than at the focusing point, as was expected. This is a persistent problem in noninvasive hyperthermia systems as well. Obviously, increase in the number of transmitting antennas will reduce the number of high-amplitude areas outside the focus area. It was also found that surface waves (at a phantom-air boundary) have considerable influence on the field distribution inside the phantom and should be taken into consideration. In addition, due to high loss in the phantom, the drug capsule should be designed for high susceptibility to electromagnetic radiation.
Drug Capsule
The inherent high losses of biological tissues at microwave frequencies make it challenging to penetrate deep into tissues with sufficient power levels. It is therefore required to have a very sensitive receiving structure on the drug capsule to absorb a significant part of the available power in order to use that energy to open the capsule. The anticipated scenario is illustrated in Figure 3 (a). A highly resonant structure, the split-ring resonator is introduced on a lid of the capsule which contains a medicine. A resonator is able to induce locally high intensity fields at the resonance frequency, compared to other frequencies (refer to Figure 3. (b) and (c)) [13] . At the resonance frequency of the SRRs on the drug capsule structure, a relatively strong electric field is generated in the gaps of the rings and in the separation between them. The alternating field induces currents in the lossy dielectric lid where part of the electric currents are converted into heat, due to power loss (Figure 2(c) ). This causes an increase of the temperature in the lid and by that, opens the capsule and releases the pharmaceutical drug. Practically this can be accomplished by having the lid constructed of a polymer, which can abruptly change its adhesion, viscosity, or permeability (a measure of the ability of a porous material to allow fluids to pass through it) when heated by just a few degrees. A layer of adhesive material, with a melting point several degrees above the ambient temperature, placed between the lid and the capsule could also operate as a release mechanism for the pharmaceutical drug. The analysis in [13] shows the existence of an optimal complex permittivity of the lid material for the highest temperature rise.
Summary
In this work, a method of externally activating and releasing pharmaceutical drugs inside the human body with the use of microwaves was investigated. Limitations of conventional technologies for external control of a drug release inside the human body formed the motivation for this study. The microwave activation system was developed on the basis of being an unobtrusive system, i.e. without disturbing the prospective patients. Four transmitters with antennas were designed to irradiate the torso phantom.
The measurement results revealed the wave behavior in the cylindrical phantom and the challenges of the focusing process. Even though focusing in the central part of the body can be achieved using the present setup, surface waves excited on the body-air interface disturbed the focusing of electromagnetic energy further away from the center of the body.
It was also found that by optimizing the complex permittivity of the capsule lid, one can maximize temperature increase in the lid. The temperature increase can then be used to open the lid and release the drugs.
